Immunocore Holdings (IMCR) Total Liabilities (2019 - 2025)
Immunocore Holdings (IMCR) has disclosed Total Liabilities for 7 consecutive years, with $686.2 million as the latest value for Q4 2025.
- Quarterly Total Liabilities rose 5.77% to $686.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $686.2 million through Dec 2025, up 5.77% year-over-year, with the annual reading at $686.2 million for FY2025, 5.77% up from the prior year.
- Total Liabilities hit $686.2 million in Q4 2025 for Immunocore Holdings, down from $705.9 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $706.8 million in Q3 2024 to a low of -$356.0 million in Q3 2023.
- Historically, Total Liabilities has averaged $352.1 million across 5 years, with a median of $641.6 million in 2024.
- Biggest five-year swings in Total Liabilities: dropped 6.28% in 2021 and later skyrocketed 298.56% in 2024.
- Year by year, Total Liabilities stood at $175.5 million in 2021, then increased by 4.74% to $183.9 million in 2022, then grew by 24.09% to $228.2 million in 2023, then skyrocketed by 184.36% to $648.8 million in 2024, then grew by 5.77% to $686.2 million in 2025.
- Business Quant data shows Total Liabilities for IMCR at $686.2 million in Q4 2025, $705.9 million in Q3 2025, and $693.9 million in Q2 2025.